Oscar Teijido

Has grant

Profesor Ayudante Doctor (Assistant Professor)

Public University of Navarre
Country flagSpain

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

NAGEN-DATA

Open Date: 2024-01-01

Close Date: 2025-01-01

Grant: Close

NAGEN-Mx

Open Date: 2021-10-01

Close Date: 2023-12-01

Grant: Close

PHARMANAGEN

Open Date: 2019-01-01

Close Date: 2021-05-01

Grant: Close

Biophysics of large membrane channels

Open Date: 2010-10-01

Close Date: 2015-06-01

Grant: Close

Regulation of early apoptosis by the proto-oncogene Bcl-2: a dangerous liaison?

Open Date: 2008-06-01

Close Date: 2009-05-01

Articles (5)

Year:

2026

Year:

2025

Year:

2024

Year:

2024

CYP2C19 is a highly polymorphic gene responsible for the metabolism of commonly used drugs. CYP2C19*1, the wild-type allele, is associated with normal enzyme activity, whereas CYP2C19*2 and CYP2C19*17 lead to null and increased enzyme activity, respectively. The use of different instruments to perform the same pharmacogenetic tests should not affect the reliability of the results reported to clinicians, as required by the ISO 15189 standard. Genotyping assays allowed for the identification of gene variants corresponding to the CYP2C19*2 and CYP2C19*17 haplotypes in 44 selected samples. Each sample was analyzed in duplicate using the Thermo Fisher Taqman Drug Metabolism probes CYP2C19*2: c_25986767_70 (rs4244285) and CYP2C19*17: c_469857_10 (rs12248560). The experiments were performed on two widely used types of real-time PCR analyzers: ABI PRSIM™7500 and QuantStudioTM12KFlex (both from Applied Biosystems, Thermofisher). The data were analyzed in a Thermo Fisher Cloud facility. The analysis was performed independently by two qualified professionals. Both different instruments and analysts’ interpretations were consistent in identifying the native homozygous, heterozygous, and mutant homozygous variants for CYP2C19*2 and CYP2C19*17. The results provided by both the primary and backup analyzers showed a perfect correlation. This would allow for the use of the backup analyzer in case the main one is not available.

Year:

2023

Collaborators (8)

Clara Sancho-Domingo

Ayudante Doctora / Assistant Professor

Public University of Navarre

SPAIN
View details

Laiene Olabarrieta Landa

Universidad de Navarra

SPAIN
View details

Diego Rivera

Docente e Investigador

Public University of Navarre

SPAIN
View details

ANGEL ALONSO

Associate Lecturer in Personalised Medicine

Universidad de Navarra

SPAIN
View details

JOSEFA SALGADO GARRIDO

Associate Lecturer

-

SPAIN
View details

Iñigo Lasa

Laboratory of Microbial pathogenesis

Universidad de Navarra

SPAIN
View details

David Gomez-Cabrero

Associate Professor

Karolinska Institutet

SWEDEN
View details

Jorge Vicente Romero

Universidad de Zaragoza

SPAIN
View details